Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Pediatric Cancer

What is Tumorigenesis?

Secondary Brain Cancer

The Biochemistry of Breast Cancer Screening

Cancer Glossary

Why are Cancer Cell Lines Useful?

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Insight into Cancer Vaccines

Insights into Oncofertility

Cancer Epidemiology

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

See more featured articles »

What is Cancer of Unknown Primary?

Cancer Symptoms

Secondary Lung Cancer

Cancer Screening Considerations: Balancing the Benefits and Risks

Acidosis and Tumor Progression

Cutaneous Manifestations of Internal Malignancy

Cancer History

Cancer Prevention: Lowering your Risk

Transforming Cancer Care through Genomic Testing

Hypoxia Markers and Their Importance

Hot vs Cold: the differences between tumor types

Cancer Pain Management

Overview of Cell Viability and Cytotoxicity

Investigating the Molecular Mechanisms of Cancer

What is Cancer?

Cancer Diagnosis

Extracellular Vesicles as Floating Cancer Biomarkers

What is Immunochemotherapy?

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Cancer Research

Effects of Social and Economic Deprivation on Cancer Mortality

Is Cancer a Metabolic Disorder?

Metastatic Migration in Cancer may be Influenced by Metabolism

Caring for a Loved One with Cancer

Cancer Classification

The Effects of Cancer on Family Life

Living with Cancer Pain

British Pioneers in Cancer Biology

What is Merkel Cell Carcinoma?

The Cancer Cell Surface Proteome as a Therapeutic Target

Cancer Prognosis

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Targeted Cancer Therapies

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Cancer Management

CDK9 and Cancer

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Assay for Monitoring and Treating Malignant Brain Tumors

TARDIS: The Improved Method of Detecting Breast Cancer

Cancer Pain

Myc Mutations and Cancer

Microfluidic cancer treatment screen combined with flow cytometry

What Role do Biobanks Play in Cancer Research?

What is the Tumor Microenvironment?

Exploiting Enzymes in Cancer Diagnosis and Therapy

Using Biomarkers to Detect Cancer

Cancer Pathophysiology

What Causes Cancer?

Latest Cancer News and Research

New oral regimen matches standard intravenous therapy for acute myeloid leukemia

The ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia (AML) is an effective alternative to the current standard, which requires repeated hospital or office visits for intravenous treatment.

1 Jun 2026

Brazilian study links TP53 mutations to poor lung cancer prognosis

Lung cancer is the most common and deadly form of cancer worldwide. It is increasingly understood to be a complex genetic disease with different mutations that vary according to factors such as smoking and ethnicity.

1 Jun 2026

Mature intestinal cells regain stem cell behavior to trigger tumor growth

In a groundbreaking study, Stevens researchers show how colorectal cancers can evolve from mature intestinal cells that revert to stem cells.

1 Jun 2026

Study shows how HIV leads to chronic pain

Over half of the people carrying HIV experience chronic pain at some point, which is difficult to treat. In a new JNeurosci paper, Hui-Lin Pan, from The University of Texas MD Anderson Cancer Center, and colleagues used mice to explore how HIV leads to chronic pain.

1 Jun 2026

New atlas provides unprecedented overview of dendritic cell diversity across cancers

Researchers from VIB, VUB, and an international network of collaborators have created the most comprehensive single-cell atlas to date of tumor-associated dendritic cells.

1 Jun 2026

Targeting microRNA pathway helps overcome cancer immunotherapy resistance

Immune checkpoint therapy, a type of cancer immunotherapy that helps the immune system recognize and attack tumors, has transformed cancer treatment.

1 Jun 2026

Study evaluates statistical models for estimating breast cancer risk

Researchers from Trinity College Dublin, St James's Hospital, and collaborating institutions have carried out the most comprehensive review to date of tools used to estimate breast cancer risk in women with a family history of the disease.

1 Jun 2026

Vaccine and drug combination cuts melanoma recurrence by half

The combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful in cutting the risk of skin cancer recurrence by 49 percent, a new study shows.

1 Jun 2026

Understanding mitochondrial biology in alcohol-associated liver disease and cancer

For decades, giant mitochondria-known as megamitochondria-have been recognized in liver biopsies from patients with alcohol-associated liver disease (ALD).

1 Jun 2026

Healthy lifestyles reduce cardiovascular risks for childhood cancer survivors

Healthy lifestyles can reduce the risk of cardiovascular disease and other complications in childhood cancer survivors.

1 Jun 2026

Laverock Therapeutics awarded in excess of £2.2 M through two innovation grants to support AI-powered platform development and to expand therapeutic programs outside of oncology

Laverock Therapeutics ('Laverock'), a biotechnology company developing disease-responsive advanced therapies through its unique, programmable gene control technology, today announced it has been awarded two new grants totaling in excess of £2.2 M to support the next generation of its gene-control platform development, and expansion into additional non-oncology therapeutics areas.

From Laverock Therapeutics 1 Jun 2026

Millions live with undiagnosed heart rhythm disorders – World Heart Rhythm Week 2026 calls for urgent action

Millions of people worldwide are living with undiagnosed heart rhythm disorders that can lead to stroke, heart failure or sudden cardiac death – often with little or no warning.

1 Jun 2026

Health workers face hidden exposure to cancer-linked hazards

A study reveals high exposure to cancer risk factors among health and social care workers in Europe, underscoring the need for enhanced protective measures.

1 Jun 2026

Global policy gaps slow biosimilar adoption and access

Nine out of 10 prescriptions are filled by generic drugs - FDA-approved carbon copies of brand-name drugs with expired patents.

1 Jun 2026

Online resources on AI and cancer lack quality, need improvement

Online information about artificial intelligence (AI) and its impact on cancer research and treatment for both the patient and general-public audiences is limited, and the available webpages and videos are largely of low quality, difficult to read, and frequently omit risks of AI use, according to new research presented today at the at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (Abstract 9000) and led by researchers from the Abramson Cancer Center (ACC) of the University of Pennsylvania and Penn's Perelman School of Medicine.

1 Jun 2026

New PET imaging tracks tumor progression and cardiac inflammation during cancer therapy

A novel PET imaging approach enables simultaneous visualization of tumor progression and cardiac inflammatory responses during cancer treatment.

1 Jun 2026

PSMA PET detects high-risk prostate cancer bone metastases

Compared to conventional imaging techniques, prostate specific membrane antigen (PSMA) PET imaging provides superior detection of bone metastases in prostate cancer patients a critical indicator of a patient's long-term survival.

1 Jun 2026

Hypoxia-gated AAV enables targeted treatment for advanced NSCLC

Adeno‑associated virus (AAV) vectors offer safety and durable expression but lack tumor specificity. This hypothesis proposes an NSCLC‑directed, hypoxia‑responsive AAV platform that integrates MGS4 peptide‑guided capsid targeting with dual hypoxia‑responsive element (HRE)‑gated promoters driving Q‑CXCL9‑Fc (chemokine) and miR‑30‑based shRNA against mesothelin (MSLN).

1 Jun 2026

New T-cell engager therapy shows effectiveness in advanced solid tumors

A team led by researchers from the National Center for Tumor Diseases (NCT/UCC) Dresden at the Carl Gustav Carus University Hospital (UKD) and the Carl Gustav Carus Faculty of Medicine at the TUD Dresden University of Technology will present clinical results for the first time on May 31, 2026, at this year’s annual meeting of the American Society of Clinical Oncology (ASCO) regarding a new cancer immunotherapy for the treatment of advanced tumors.

1 Jun 2026

Novel PRRT approach shows promise in advanced neuroendocrine tumors

A new type of peptide receptor radionuclide therapy (PRRT) appears to be safe in metastatic neuroendocrine tumor patients who have exhausted conventional treatment options.

31 May 2026